当前位置: 首页 > 详情页

MiR-214-3p attenuates cognition defects via the inhibition of autophagy in SAMP8 mouse model of sporadic Alzheimer's disease

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [a]Department of Neurology of Weifang People’s Hospital, Weifang 261041, Shandong, PR China [b]Department of Medical Laboratory of Beijing Children’s Hospital, Capital Medical University, Beijing 100053, PR China [c]Clinical Laboratory of Xuanwu Hospital, Capital Medical University, Beijing 100053, PR China
出处:
ISSN:

关键词: Autophagy miR-214-3p Sporadic Alzheimer's disease Atg12 Apoptosis

摘要:
The autophagy process is the major cellular degradation pathway for long-lived proteins and organelles. Dysfunction of autophagy may lead to several neurodegenerative disorders. However, the regulation and function of autophagy in sporadic Alzheimer's disease (SAD) remain unclear. In this study, we established SAMP8 mouse as a suitable SAD model and performed microarray profiling to identify miR-214-3p as a SAD associated microRNA that was downregulated in hippocampal neurons of SAMP8 mice upon the induction of autophagy. Furthermore, decreased miR-214-3p level was detected in cerebrospinal fluid from SAD patients. Overexpression of miR-214-3p in primary neurons from SAMP8 mice inhibited autophagy, demonstrated by decreased levels of LC3 beta II and Beclin1, and reduced number of GFP-LC3-positive autophagosome vesicles, and led to increased viability and decreased caspase-mediated apoptosis. Conversely, antagomiR-214-3p promoted autophagy and apoptosis in neurons from SAMP8 mice. Mechanistically, miR-214-3p negatively regulated Atg12 expression by targeting the 3'-untranslated region of Atg12. Treatment of SAMP8 mice with miR-214-3p attenuated neuronal apoptosis and improved behavioral performance. Taken together, these results suggest that miR-214-3p suppresses autophagy and alleviates hippocampal neuron apoptosis, which indicates that miR-214-3p represents a new potential neuroprotective factor for SAD. (C) 2016 Elsevier B.V. All rights reserved.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2015]版:
大类 | 3 区 医学
小类 | 3 区 药学 3 区 毒理学 4 区 神经科学
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 药学 3 区 毒理学 4 区 神经科学
JCR分区:
出版当年[2014]版:
Q1 TOXICOLOGY Q2 PHARMACOLOGY & PHARMACY Q2 NEUROSCIENCES
最新[2023]版:
Q2 NEUROSCIENCES Q2 PHARMACOLOGY & PHARMACY Q2 TOXICOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2014版] 出版当年五年平均 出版前一年[2013版] 出版后一年[2015版]

第一作者:
第一作者机构: [a]Department of Neurology of Weifang People’s Hospital, Weifang 261041, Shandong, PR China
共同第一作者:
通讯作者:
通讯机构: [c]Clinical Laboratory of Xuanwu Hospital, Capital Medical University, Beijing 100053, PR China [*1]Xuanwu Hospital, Capital Medical University, 45 Changchun Street, Xicheng District, Beijing, 100053, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16461 今日访问量:0 总访问量:871 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院